Colon Cancer
Colorectal cancer treatment is not consistent between races and ethnicities
Published in Clinical Oncology Week, November 21st, 2005
According to a recent review from Pennsylvania, "Multiple studies have demonstrated that black patients have a less favorable prognosis and suffer higher death rates from colorectal cancer than whites. After more than 40 years of 5-fluorouracil (5-FU)-based therapy, the introduction of new agents such as irinotecan, oxaliplatin, and capecitabine in the past decade has revolutionized the treatment of colorectal cancer."
"Although 5-FU remains an important part of most regimens, irinotecan and oxaliplatin are now essential components of front-line therapy. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Cancer Therapy
Progressive muscle relaxation training reduced chemotherapy side effects - Diagnostics
Digital rectal examination cited as barrier to prostate cancer screening - Palliative Care
Methotrimeprazine used in management of nausea and vomiting in advanced cancer - Prognostics
Age and race should not be used as factors in prostate cancer treatment decision-making - Prognostics
Circulating plasma cells predicted survival in patients with newly diagnosed multiple myeloma - Acute Myeloid Leukemia
Phase II study to evaluate Xanafide in combination with ara-C for secondary AML - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
